Last Updated on January 6, 2024 by The Health Master
Pharmaceutical MSME
Pharmaceutical MSME: In a significant revelation, recent data from the Department of Pharmaceuticals (DoP) as of August 1, 2023, underscores the concentration of pharmaceutical Micro, Small, and Medium Enterprises (MSMEs) in specific states across India.
This insightful report sheds light on the pivotal role played by states like Maharashtra, Uttar Pradesh, Gujarat, and Tamil Nadu in the pharmaceutical sector.
| Size of the Enterprise | Investment and Annual Turnover |
| Micro | Investment less than Rs. 1 crore Turnover less than Rs. 5 crore |
| Small | Investment less than Rs. 10 crore Turnover up to Rs. 50 crore |
| Medium | Investment less than Rs. 20 crore Turnover up to Rs. 100 crore |
State-wise Breakdown
- Maharashtra: Leading the Pack
- Total Companies: 17,760
- Uttar Pradesh: Following Strong
- Total Companies: 10,674
- Gujarat: Making its Mark
- Total Companies: 8,898
- Tamil Nadu: A Strong Contender
- Total Companies: 7,418
- Delhi: Holding Ground
- Total Companies: 5,426
- Rajasthan: A Steady Presence
- Total Companies: 4,522
- Haryana: Making Strides
- Total Companies: 4,180
- Telangana: A Growing Hub
- Total Companies: 4,128
- Karnataka: Gaining Momentum
- Total Companies: 3,751
- Madhya Pradesh: In the Mix
- Total Companies: 3,664
This data affirms that these ten states host a substantial 76 percent of the total pharmaceutical MSMEs in the country.
Underrepresented Regions
On the flip side, several states and Union Territories showcase a lower number of MSME registrations in the sector, indicating room for growth and development:
- Ladakh: 9 Registrations
- Sikkim: 12 Registrations
- Meghalaya: 17 Registrations
- Arunachal Pradesh: 21 Registrations
- Nagaland: 26 Registrations
- Andaman and Nicobar Islands: 34 Registrations
- Tripura: 40 Registrations
- Mizoram: 46 Registrations
District-level Insights
Unpacking the data further, we find that certain districts have emerged as focal points for pharmaceutical and related MSMEs:
- Ahmedabad: 3,475 Registrations
- Pune: 2,763 Registrations
- Thane: 2,602 Registrations
- Mumbai: 2,128 Registrations
- Bengaluru – Urban: 1,925 Registrations
- Jaipur: 1,878 Registrations
- Hyderabad: 1,745 Registrations
- Mumbai Suburban: 1,731 Registrations
- Chennai: 1,641 Registrations
- Lucknow: 1,426 Registrations
Conversely, some districts report a more modest presence, with only a single registered company in the sector.
Government Initiatives
The Department of Pharmaceuticals, in tandem with the Ministry of Chemicals and Fertilizers, has embarked on several initiatives to bolster and facilitate the growth of MSMEs in the pharmaceutical sector.
Minister of State, Bhagwanth Khuba, highlighted these measures during the latest Parliament Session:
1. Production Linked Incentive (PLI) Scheme:
- Financial Outlay: Rs. 6,940 crore
- Tenure: FY 2020-2021 to FY 2029-30
- Selection of 12 MSME companies for 15 projects
2. Pharmaceutical PLI Scheme:
- Financial Outlay: Rs. 15,000 crore
- Tenure: FY 2020-2021 to FY 2028-29
- Incentivizing 55 selected applicants across three product categories
- 20 MSME companies selected under Group-C category
3. Strengthening of the Pharmaceutical Industry (SPI):
- Financial Outlay: Rs. 500 crore
- Tenure: FY 2021-2022 to FY 2025-26
- Two-pronged approach: infrastructure support for pharma MSMEs in clusters and technology upgradation of individual pharma MSMEs.
These initiatives aim to reduce import dependence, stimulate domestic manufacturing, and attract substantial investments in the Pharmaceutical MSME sector.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Breakthrough Pediatric HIV Treatment Receives Tentative USFDA Approval
DCC proposes crucial amendments for enhancing Drug Regulation
USFDA Approval granted for Generic Sevelamer Carbonate Oral Suspension
Drug alert: DCGI issues alerts on two Falsified Drugs
Nutraceuticals in India: A step towards empowering Pharma Industry
DCC recommends Transparent Packaging for Eye Drops
USFDA approval granted for Generic Pirfenidone Capsules
Natco Pharma faces Antitrust Lawsuit over generic Cancer Drug
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
